Funding Rounds
SynOx Therapeutics

SynOx Therapeutics Series B (2024, $75M)

SynOx Therapeutics

Developer of treatment for diffuse tenosynovial giant cell tumors.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series B

Raised Amount: $75.00M

Investors